SCHEMBL7258770

SCHEMBL7258770

O=S(=O)(O)Nc1ccc2c(c1)CCC2

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.58
SMN1; SMN2 Q16637 4/20 0.58
LMNA P02545 3/20 0.58
THRB P10828 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
NPSR1 Q6W5P4 1/20 0.56
POLB P06746 3/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
CA12 O43570 1/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
CA9 Q16790 1/20 0.51
NPC1 O15118 7/20 0.50
RAB9A P51151 7/20 0.50
PTPN7 P35236 1/20 0.50
NFKB1 P19838 2/20 0.49
NFKB2 Q00653 2/20 0.49
RELA Q04206 2/20 0.49
TP53 P04637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18422825 0.83 LMNA (0.64) ALDH1A1SMN1; SMN2LMNATHRBL3MBTL1
SCHEMBL30023674 0.83 LMNA (0.64) ALDH1A1SMN1; SMN2LMNATHRBL3MBTL1
SCHEMBL27183420 0.80 LMNA (0.60) ALDH1A1SMN1; SMN2LMNATHRBL3MBTL1
SCHEMBL15220226 0.79 LMNA (0.59) ALDH1A1SMN1; SMN2LMNATHRBL3MBTL1
SCHEMBL27803929 0.78 HTR6 (0.54)
SCHEMBL6925873 0.78 PNMT (0.56)
SCHEMBL7262332 0.78 TRPV1 (0.64) ALDH1A1SMN1; SMN2LMNAPOLBMEN1
SCHEMBL7262334 0.78 TRPV1 (0.64) ALDH1A1SMN1; SMN2LMNAPOLBMEN1
SCHEMBL13369892 0.74 NPC1 (0.53) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
SCHEMBL22516003 0.74 ALDH1A1 (0.74) ALDH1A1SMN1; SMN2LMNATHRBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003082263-A1 SULFAMIC ACIDS AS INHIBITORS OF HUMAN CYTOPLASMIC PROTEIN TYROSINE PHOSPHATASES ONTOGEN CORPORATION (US) 2003-10-09 WO disclosed